Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway.
Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway.
复制标题
Neferine 通过调节 PI3K/AKT/mTOR 信号通路的抗细胞凋亡和抗氧化作用改善脓毒症引起的心肌功能障碍
DOI:
10.3389/fphar.2021.706251
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Qi Z;Wang R;Liao R;Xue S;Wang Y
Septic cardiomyopathy is a common complication of severe sepsis, which is one of the leading causes of death in intensive care units. Therefore, finding an effective therapy target is urgent. Neferine is an alkaloid extracted from the green embryos of mature seeds of Nelumbo nucifera Gaertn., which has been reported to exhibit various biological activities and pharmacological properties. This study aims to explore the protective effects of neferine against lipopolysaccharide (LPS)-induced myocardial dysfunction and its mechanisms. The LPS-induced cardiac dysfunction mouse model was employed to investigate the protective effects of neferine. In this study, we demonstrated that neferine remarkably improved cardiac function and survival rate and ameliorated morphological damage to heart tissue in LPS-induced mice. Neferine also improved cell viability and mitochondrial function and reduced cell apoptosis and the production of reactive oxygen species in LPS-treated H9c2 cells. In addition, neferine significantly upregulated Bcl-2 expression and suppressed cleaved caspase 3 activity in LPS-induced mouse heart tissue and H9c2 cells. Furthermore, neferine also upregulated the phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR) signaling pathway in vivo and in vitro. Conversely, LY294002 (a PI3K inhibitor) reversed the protective effect of neferine in LPS-induced H9c2 cells. Our findings thus demonstrate that neferine ameliorates LPS-induced cardiac dysfunction by activating the PI3K/AKT/mTOR signaling pathway and presents a promising therapeutic agent for the treatment of LPS-induced cardiac dysfunction.
登录
查看更多内容
影响因子:
3.7
作者:
Braun CK;Kalbitz M;Halbgebauer R;Eisele P;Messerer DAC;Weckbach S;Schultze A;Braumüller S;Gebhard F;Huber-Lang MS
通讯作者:
Huber-Lang MS
影响因子:
5.3
作者:
Chen L;Liu P;Feng X;Ma C
通讯作者:
Ma C
影响因子:
5.6
作者:
Liu L;Yan M;Yang R;Qin X;Chen L;Li L;Si J;Li X;Ma K
通讯作者:
Ma K
影响因子:
6
作者:
Baskaran, Rathinasamy;Poornima, Paramasivan;Padma, Viswanadha Vijaya
通讯作者:
Padma, Viswanadha Vijaya
影响因子:
4.6
作者:
Priya LB;Baskaran R;Huang CY;Padma VV
通讯作者:
Padma VV